Achieving Resilience in Acute Care Nurses (ARISE).

April 16, 2018 updated by: Orla Smith, Unity Health Toronto

Achieving Resilience in Acute Care Nurses (ARISE): A Randomized Controlled Trial of a Multi-component Intervention for Nurses in Critical Care and Trauma.

Nurses are exposed to myriad stressors, both in the workplace and in their everyday lives, which can lead to adverse personal and professional outcomes. While workplace stress cannot be eliminated, nurses can learn techniques to build resilience, mitigate stress, and decrease fatigue. Organizational employee health, wellness, and assistance programs are all intentioned to provide this type of support; however, nurses often lack awareness of options and opportunities, and access can be a challenge. The purpose of the proposed study is to assess the outcomes of a multi-modal intervention and toolkit, ARISE, designed to enhance resilience and promote awareness of organizational resources for health, wellness, and employee assistance. We will evaluate the impact of participation in ARISE on resilience and other outcomes in nurses in critical care and trauma settings. As a Best Practice Spotlight Organization designated by the Registered Nurses Association of Ontario (RNAO), this project will incorporate relevant recommendations from Best Practice Guidelines (BPG) related to Workplace Health, Safety, and Well-being of the Nurse; and Preventing and Mitigating Nurse Fatigue in Health Care.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Toronto, Ontario, Canada, M5B1W8
        • St. Michael's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nurse in the medical-surgical and trauma-neurosurgical intensive care units (MSICU and TNICU) and the medical/surgical floor (9CCN),
  • full-time or part-time employment status,
  • approval of clinical leader manager (CLM),
  • receipt of written informed consent.

Exclusion Crieria:

  • casual employment status
  • inability to attend intervention days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ARISE Intervention
Nurses who participate in the 1.5 day ARISE Intervention
Other: ARISE
  1. Full day (7.5 hours) workshop consisting of a resilience-focused seminar facilitated by our Employee Assistance Provider (EAP) [Shepell], an introduction to hospital based resources including EAP and health and wellness offerings, and an introduction to self-care and self-care techniques including yoga and stretches, stress relief using the senses and mindfulness
  2. Half day (3.75 hours) workshop focusing on the following self-care techniques: mindfulness, yoga and stretching, and creative and reflective reading and writing
  3. Peer support through social media engagement (closed Facebook group) for 3 months post-intervention participation
  4. Five online, instructor-guided mindfulness sessions (Zoom)
No Intervention: Control Group
Nurses who do not participate in the ARISE Intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Connor Davidson Resilience Scale (CD-RISC)
Time Frame: 1 month post intervention
1 month post intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Connor Davidson Resilience Scale (CD-RISC)
Time Frame: 3 months post intervention
3 months post intervention
Occupational fatigue and recovery (OFER) scale
Time Frame: 1 month post intervention
Acute fatigue and inter-shift recovery scales only
1 month post intervention
Occupational fatigue and recovery (OFER) scale
Time Frame: 3 months post intervention
Acute fatigue and inter-shift recovery scales only
3 months post intervention
Professional Quality of Life (ProQOL5) scale
Time Frame: 1 month post intervention
1 month post intervention
Professional Quality of Life (ProQOL5) scale
Time Frame: 3 months post intervention
3 months post intervention
Perceived Stress Scale (PSS)
Time Frame: 1 month post intervention
1 month post intervention
Perceived Stress Scale (PSS)
Time Frame: 3 months post intervention
3 months post intervention
Occupational Coping Self-Efficacy Questionnaire for Nurses (OCSE-N).
Time Frame: 1 month post intervention
1 month post intervention
Occupational Coping Self-Efficacy Questionnaire for Nurses (OCSE-N).
Time Frame: 3 months post intervention
3 months post intervention
Mindfulness Attention Awareness Scale (MASS)
Time Frame: 1 month post intervention
1 month post intervention
Mindfulness Attention Awareness Scale (MASS)
Time Frame: 3 months post intervention
Mindfulness attention awareness will be measured using the Mindfulness Attention Awareness Scale (MASS).
3 months post intervention
Program Evaluation Outcomes for ARISE participants
Time Frame: 1 month post intervention
For each component of the intervention, and for the ARISE program as a whole, we will ask participants to rate utility, satisfaction, and frequency of use of intervention components.
1 month post intervention
Program Evaluation Outcomes for ARISE participants
Time Frame: 3 months post intervention
For each component of the intervention, and for the ARISE program as a whole, we will ask participants to rate utility, satisfaction, and frequency of use of intervention components.
3 months post intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Unity Health Toronto

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 21, 2017

Primary Completion (Actual)

May 31, 2017

Study Completion (Actual)

October 15, 2017

Study Registration Dates

First Submitted

January 9, 2017

First Submitted That Met QC Criteria

January 9, 2017

First Posted (Estimate)

January 11, 2017

Study Record Updates

Last Update Posted (Actual)

April 17, 2018

Last Update Submitted That Met QC Criteria

April 16, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SMH30Dec2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress, Psychological

Clinical Trials on ARISE

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Russia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe